Comparing Invega Sustenna vs Rexulti
| Invega Sustenna (paliperidone) | Rexulti (brexpiprazole) |
|
|---|
| Invega Sustenna (paliperidone) | Rexulti (brexpiprazole) |
|
|||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Prescription only
Invega Sustenna is a long-acting form of paliperidone that is injected into the deltoid or gluteal muscle once a month after an initial loading dose. It is similar in its pharmacology and action to... View more |
Prescription only
Rexulti is an atypical antipsychotic that may be used to treat adults with schizophrenia or depression, or used to relieve agitation associated with dementia in Alzheimer's disease. Most people... View more |
Related suggestions Schizophrenia
Popular comparisons
|
|||||||||||||||
| More about Invega Sustenna (paliperidone) | More about Rexulti (brexpiprazole) | ||||||||||||||||
| Ratings & Reviews | |||||||||||||||||
|
Invega Sustenna has an average rating of 3.9 out of 10 from a total of 192 ratings on Drugs.com. 27% of reviewers reported a positive effect, while 59% reported a negative effect. |
Rexulti has an average rating of 6.6 out of 10 from a total of 489 ratings on Drugs.com. 54% of reviewers reported a positive effect, while 26% reported a negative effect. |
||||||||||||||||
| Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | |||||||||||||||||
View all Invega Sustenna side effects |
View all Rexulti side effects |
||||||||||||||||
| Drug Class | |||||||||||||||||
| Generic Availability | |||||||||||||||||
| Pricing and Coupons * Prices are without insurance | |||||||||||||||||
View all Invega Sustenna prices |
View all Rexulti prices |
||||||||||||||||
| Dosage Forms | |||||||||||||||||
|
|
||||||||||||||||
| Brand Names | |||||||||||||||||
| Other paliperidone brands include: Erzofri, Invega, Invega Hafyera, Invega Trinza |
N/A |
||||||||||||||||
| Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | |||||||||||||||||
|
23 hours |
91 hours |
||||||||||||||||
| CSA Schedule 1 View glossary of CSA terms | |||||||||||||||||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||
| Pregnancy Category | |||||||||||||||||
|
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Summary unavailable. See the full pregnancy warnings document. |
||||||||||||||||
| Drug Interactions | |||||||||||||||||
|
A total of 629 drugs are known to interact with Invega Sustenna:
|
A total of 599 drugs are known to interact with Rexulti:
|
||||||||||||||||
| Alcohol/Food/Lifestyle Interactions | |||||||||||||||||
|
|
||||||||||||||||
| Disease Interactions | |||||||||||||||||
| First Approval Date | |||||||||||||||||
|
July 31, 2009 |
July 10, 2015 |
||||||||||||||||
| WADA Class View classifications | |||||||||||||||||
|
N/A |
N/A |
||||||||||||||||
| More Information | |||||||||||||||||
| Patient Resources | |||||||||||||||||
| Professional Resources | |||||||||||||||||
| Related Treatment Guide | |||||||||||||||||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.